首页> 美国卫生研究院文献>Journal of Inflammation (London England) >CCR5 signalling but not DARC or D6 regulatory chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway
【2h】

CCR5 signalling but not DARC or D6 regulatory chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway

机译:CCR5信号传导但不是DARC或D6调控趋化因子受体被疱疹病毒U83A趋化因子靶向该趋化因子通过转移至小窝蛋白连接途径来延迟受体内在化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHerpesviruses have evolved chemokines and chemokine receptors, which modulate the recruitment of human leukocytes during the inflammatory response to infection. Early post-infection, human herpesvirus 6A (HHV-6A) infected cells express the chemokine receptor U51A and chemokine U83A which have complementary effects in subverting the CC-chemokine family thereby controlling anti-viral leukocyte recruitment. Here we show that, to potentiate this activity, the viral chemokine can also avoid clearance by scavenger chemokine receptors, DARC and D6, which normally regulate an inflammatory response. Conversely, U83A delays internalisation of its signalling target receptor CCR5 with diversion to caveolin rich membrane domains. This mechanism can redirect displaced human chemokines to DARC and D6 for clearance of the anti-viral inflammatory response, leaving the viral chemokine unchecked.
机译:背景疱疹病毒已经进化出趋化因子和趋化因子受体,它们在感染的炎症反应过程中调节人白细胞的募集。感染后早期,人类疱疹病毒6A(HHV-6A)感染的细胞表达趋化因子受体U51A和趋化因子U83A,它们在颠覆CC趋化因子家族从而控制抗病毒白细胞募集方面具有互补作用。在这里,我们表明,为了增强这种活性,病毒趋化因子还可以避免清除剂趋化因子受体DARC和D6清除,该受体通常调节炎症反应。相反,U83A转移至富含小孔膜的膜结构域,从而延迟了其信号传导靶受体CCR5的内在化。该机制可以将置换的人趋化因子重定向至DARC和D6,以清除抗病毒的炎症反应,从而使病毒趋化因子不受控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号